About heart rhythm disturbances in patients after the coronavirus infection

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

A review of foreign and domestic scientific literature containing data on the frequency, pathogenesis and treatment of atrial fibrillation in coronavirus infection is presented. This topic was chosen because of its relevance, prevalence of morbidity and possible complications. A separate part of the publication is devoted to the study of the pathogenesis of arrhythmia during the period of the disease, the knowledge of which contributes to an integrated approach to therapy. The tactics of managing patients with atrial fibrillation during a coronavirus infection are considered.

作者简介

V. Steklov

The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation; Branch The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

编辑信件的主要联系方式.
Email: vsteklov@yandex.ru

заслуженный врач РФ, доктор медицинских наук, полковник медицинской службы запаса

俄罗斯联邦, Moscow; Moscow

N. Morozova

The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: vsteklov@yandex.ru
俄罗斯联邦, Moscow

L. Silant’eva

9th Medical and Diagnostic Center of the Ministry of Defense of the Russian Federation

Email: natsy81@yandex.ru
俄罗斯联邦, Moscow

E. Alimova

Branch The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

Email: natsy81@yandex.ru
俄罗斯联邦, Moscow

S. Gustova

Branch The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

Email: natsy81@yandex.ru
俄罗斯联邦, Moscow

参考

  1. Анисенкова А.Ю., Вологжанин Д.А., Голота А.С. и др. Цитокиновый шторм при COVID-19 (научный обзор) // Профилакт. и клин. мед. – 2021. – № 1. – С. 89–95.
  2. Аракелян М.Г., Бокерия Л.А., Васильева Е.Ю. и др. Фибрилляция и трепетание предсердий. Клинические рекомендации 2020 // Рос. кардиол. журн. – 2021. – № 7. – С. 190–260.
  3. Зайцев А.А., Чернов С.А., Стец В.В., Паценко М.Б., Кудряшов О.И., Чернецов В.А., Крюков Е.В. Алгоритмы ведения пациентов с новой коронавирусной инфекцией COVID-19 в стационаре: Метод. реком. // Consilium Medicum. – 2020. – Т. 22, № 11. – С. 91–97.
  4. Мясников Р.П., Щербакова Н.В., Куликова О.В. и др. Мутация гена DES в семье пробанда с миофибриллярной миопатией и развитием некомпактной кардиомиопатии, приведшей к трансплантации сердца // Рос. кардиол. журн. – 2017. – № 10 (150). – С. 9–16.
  5. Напалков Д.А., Соколова А.А., Скрипка А.И. Особенности ведения пациентов с фибрилляцией предсердий во время пандемии COVID-19: актуальные вопросы и возможные ответы // Consilium Medicum. – 2021. – Т. 23, № 1.– С. 32–34.
  6. Поляков А.С., Тыренко В.В., Крюков Е.В. и др. Оптимальный выбор антикоагулянтной профилактики при неклапанной фибрилляции предсердий в период пандемии COVID-19 // Рос. кардиол. журн. – 2021. – № 8. – С. 76–82.
  7. Aghagoli G., Gallo M.B., Soliman L.B. et al. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review // J. of card. surgery. – 2020. – Vol. 35, N 6. – P. 1302–1305.
  8. Chen D., Li X., Song Q. et al. Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China // JAMA network open. – 2020. – Vol. 3, N 6. – P. e2011122–e2011122.
  9. Chorin E., Wadhwani L., Magnani S. et al. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin // Heart rhythm. – 2020. – Vol. 17, N 9. – P. 1425–1433.
  10. Garcia-Granja P.E., Veras C., Aparisi А. et al. Atrial fibrillation in patients with SARS-CoV-2 infection // Med. Clin. (English Edition). – 2021. – Vol. 157, N 2. – P. 58–63.
  11. Ghantous E., Szekely Y., Lichter Y. et al. Pericardial Involvement in Patients Hospitalized With COVID-19: Prevalence, Associates, and Clinical Implications // J. Am. Heart Assoc. – 2022. – Vol. 11, N 7. – P. e024363.
  12. Inciardi R.M., Adamo M., Lupi L. et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy // Eur. Heart J. – 2020. – Vol. 41, N 19. – P. 1821–1829.
  13. Lazzerini P.E., Boutjdir M., Capecchi P.L. COVID-19, arrhythmic risk, and inflammation: mind the gap! // Circulation. – 2020. – Vol. 142, N 1. – P. 7–9.
  14. Madjid M., Vela D., Khalili-Tabrizi H. et al. Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes // Tex. Heart Inst. J. – 2007. – Vol. 34, N 1. – P. 11–18.
  15. Peretto G., Sala S., Rizzo S. Arrhythmias in myocarditis: state of the art // Heart rhythm. – 2019. – Vol. 16, N 5. – P. 793–801.
  16. Simpson T., Salazar J., Vittinghoff E. et al. Association of QT prolonging medications with risk of autopsy causes of sudden death // JAMA intern. med. – 2020. – Vol. 180, N 5. – P. 698–706.
  17. Siripantong B., Nazarian S., Muser D. Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management // Heart rhythm. – 2020. – Vol. 17, N 9. – P. 1463–1471.
  18. Varga Z., Flammer A.J., Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19 // The Lancet. – 2020. – Vol. 395, N 10234. – P. 1417–1418.
  19. Wang D., Hu B., Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China // Jama. – 2020. – Vol. 323, N 11. – P. 1061–1069.
  20. Xie Y., Xu E., Bowe B. et al. Long-term cardiovascular outcomes of COVID-19 // Nature med. – 2022. – Vol. 28, N 3. – P. 583–590.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Steklov V.I., Morozova N.V., Silant’eva L.B., Alimova E.R., Gustova S.V., 2022


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.
##common.cookie##